CRDL Insider Trading

Insider Ownership Percentage: 4.42%
Insider Buying (Last 12 Months): C$0.00
Insider Selling (Last 12 Months): C$0.00

Cardiol Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Cardiol Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cardiol Therapeutics Share Price & Price History

Current Price: C$2.97
Price Change: Price Increase of +0.04 (1.37%)
As of 05/21/2024 11:07 AM ET

This chart shows the closing price history over time for CRDL up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Cardiol Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/28/2022Guillermo TorreSenior OfficerBuy18,245C$0.52C$9,441.79
See Full Table

SEC Filings (Institutional Ownership Changes) for Cardiol Therapeutics (TSE:CRDL)

13.04% of Cardiol Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Cardiol Therapeutics logo
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx for patients hospitalized with COVID-19, as well as for the treatment of recurrent pericarditis and acute myocarditis. The company is also developing subcutaneous formulation of CardiolRx for the treatment of fibrosis and inflammation in the heart that is related with the development and progression of heart failure. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.
Read More on Cardiol Therapeutics

Today's Range

Now: C$2.97
Low: C$2.95
High: C$3.02

50 Day Range

MA: C$2.52
Low: C$1.89
High: C$3.22

52 Week Range

Now: C$2.97
Low: C$0.87
High: C$3.27

Volume

16,363 shs

Average Volume

134,481 shs

Market Capitalization

C$202.76 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.68

Who are the company insiders with the largest holdings of Cardiol Therapeutics?

Cardiol Therapeutics' top insider investors include:
  1. Guillermo Torre (Senior Officer)
Learn More about top insider investors at Cardiol Therapeutics.